KalVista Pharmaceuticals (KALV) Reports Q2 Loss of $0.22/Share

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q2 EPS of ($0.22), versus ($0.50) reported last year. Revenue for the quarter came in at $5.59 million, versus $1.13 million reported last year.

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Equinor ASA (ADR) (EQNR) PT Lowered to $37 at TD Cowen
• Jefferies Assumes Radico Khaitan Ltd (RDCK:IN) at Buy